Form 4: Danaher CFO Exercises Options, Sells Shares
Insider Transaction Report
Danaher Corporation's EVP & Chief Financial Officer, Matthew McGrew, exercised stock options and subsequently sold an equal number of common shares.
Summary
- Matthew McGrew, Executive Vice President & Chief Financial Officer of Danaher Corp (DHR), reported transactions on November 11, 2025.
- McGrew exercised employee stock options to acquire 16,172 shares of common stock at an exercise price of $62.85 per share.
- Immediately following the option exercise, McGrew sold 16,172 shares of common stock on the open market.
- The shares were sold at a weighted average price of $214.6198, with individual transaction prices ranging from $214.580 to $214.810.
- After these transactions, McGrew directly beneficially owns 20,062 shares of common stock.
- Additionally, McGrew indirectly beneficially owns 10,221.856 shares of common stock through a 401(k) plan.
Sentiment
Score: 6
Explanation: The filing reports an executive's exercise of stock options and subsequent sale of shares, a common practice for executive compensation and liquidity management. It reflects the executive realizing value from previously granted options, which is generally neutral to slightly positive, as it's a planned event.
Positives
- The executive is realizing value from previously granted stock options, which is a common component of executive compensation and reflects the company's past stock performance.
Negatives
- The sale of shares by an executive, even if pre-planned, can sometimes be perceived negatively by investors, though it is a routine part of executive liquidity management.
Future Outlook
This Form 4 filing is a transactional report and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing reports a routine insider transaction for an executive at a diversified global science and technology innovator. Such transactions are common across industries as part of executive compensation and personal financial planning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Transaction Disclosure | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/11/2025 | Indicates a pre-arranged trading plan, which helps mitigate concerns about opportunistic insider trading and aligns with good corporate governance practices. |
Stakeholder Impact
- Shareholders: May view the executive's sale as a routine liquidity event, especially given the 10b5-1 plan disclosure, rather than a signal of lack of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 11/15/2015 | Grant date of the employee stock options, which became exercisable in thirds on the third, fourth, and fifth anniversaries. |
| 11/11/2025 | Date of the reported transactions, including the exercise of stock options and the sale of common stock. |
| 11/13/2025 | Date the Form 4 was signed by the attorney-in-fact for Matthew McGrew. |
| 11/15/2025 | Expiration date of the employee stock options. |
Recommendation
holdThe Form 4 details a routine insider transaction where the EVP & CFO exercised stock options and immediately sold the acquired shares. This is a common practice for executive compensation and liquidity, often executed under a pre-arranged 10b5-1 plan. It does not indicate a change in the company's fundamental outlook or performance, thus a 'hold' recommendation is appropriate.
Keywords
Danaher, DHR, Matthew McGrew, Form 4, Insider Trading, Stock Option Exercise, Share Sale, CFO, Executive Compensation, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.